Effect of Perinatal Antiretroviral Drug Exposure on Hematologic Values in HIV‐Uninfected Children: An Analysis of the Women and Infants Transmission Study
The Journal of Infectious Diseases2006Vol. 194(8), pp. 1089–1097
Citations Over TimeTop 10% of 2006 papers
Susan E. Pacheco, Kenneth McIntosh, Mingjian Lu, Lynne Mofenson, Clemente Díaz, Marc Foca, Margaret Frederick, Edward Handelsman, Karen Hayani, William T. Shearer, Women and Infants Transmission Study
Abstract
Infants exposed to ARV drugs have small but significant differences in several hematologic parameters for the first 24 months of life. These results indicate the need for long-term follow-up of uninfected infants with ARV exposure.
Related Papers
- Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.(1990)
- → Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Does Not Adversely Affect Outcome at 1 Year(1996)37 cited
- Characterization of zidovudine resistant variants of HIV-1 isolated from patients on prolonged therapy.(1992)
- → Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine(1988)32 cited
- → Changes in T-lymphocyte subpopulations during pregnancy complicated by human immunodeficiency virus infection(1992)10 cited